FDA Drug Application (202884) for CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE by APOTEX INC

Back to FDA Applications sponsored by APOTEX INC

Application Number202884
Product Number001
FormTABLET;ORAL
Dosage16MG;12.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
Active IngredientCANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient CANDESARTAN CILEXETIL5
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122


Back to FDA Applications sponsored by APOTEX INC